Skip to search formSkip to main contentSkip to account menu

E 6010

Known as: E-6010, E6010 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Epidermal Growth Factor

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Effects of recombinant tissue-type plasminogen activator on life-threatening acute pulmonary thromboembolism in a canine model: a comparative study of e6010 and alteplase.
We compared the effects a novel recombinant tissue-type plasminogen activator (rt-PA) E6010 with the more conventional… 
1996
1996
遺伝子組換えヒト組織性Plasminogen Activator (rt-PA) 誘導体 (E6010) の体内動態に関する研究 (1) : ラットに ^ I-標識E6010を単回静脈内投与した時の血中濃度推移, 分布, 代謝および排泄の ^ I-標識 rt-PAとの比較検討
1995
1995
A novel modified t-PA, E-6010, induces faster recovery of ventricular function after coronary thrombolysis than native t-PA in a canine thrombosis model.
Using the centerline method in a canine model, we compared left ventricular function after coronary thrombolysis induced by a… 
1995
1995
A novel modified tissue-type plasminogen activator (t-PA), E6010, reduces reperfusion arrhythmias induced after coronary thrombolysis--comparison of native t-PA and urokinase.
The aim of this study was to compare the effects of a novel modified tissue-type plasminogen activator (t-PA), E6010, to those of… 
1995
1995
Thrombolytic properties of a novel modified human tissue-type plasminogen activator (E6010) : a bolus injection of E6010 has equivalent potency of lysing young and aged canine coronary thrombi
1994
1994
Thrombolytic effects of a novel modified recombinant tissue plasminogen activator, E6010, on rat arterio-venous shunt model
1994
1994
A novel modified tissue-type plasminogen activator (t-PA), E6010, gradually increases coronary blood flow after thrombolysis compared with native t-PA, urokinase and balloon catheter occlusion…
In a canine copper coil-induced coronary thrombosis model, the differences in frequency of reperfusion arrhythmias (premature… 
1993
1993
Intracoronary Infusion of E6010 Has More Potent Thrombolytic Activity Than Tissue Plasminogen Activator (t-PA) in Dogs: A Higher Plasma Level of E6010 Than t-PA Causes Potent Thrombolytic Activity
Summary: We examined the thrombolytic properties of a novel modified human tissue plasminogen activator (PA) (E6010), in which… 
1992
1992
Multicenter trial of a novel modified t-PA, E6010, by i.v.bolus injection in patients with acute myocardial infarction.
1992
1992
Thrombolytic effects of a novel modified tissue plasminogen activator, E6010, on coronary thrombosis in the pig.
This study was conducted to compare the thrombolytic effect of a novel modified tissue plasminogen activator, E6010, with that of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)